-
1
-
-
2942720573
-
The nature of small-airway obstruction in chronic obstructive pulmonary disease
-
DOI 10.1056/NEJMoa032158
-
Hogg JC, Chu F, Utokaparch S et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004; 350: 2645-53. (Pubitemid 38787999)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.26
, pp. 2645-2653
-
-
Hogg, J.C.1
Chu, F.2
Utokaparch, S.3
Woods, R.4
Elliott, W.M.5
Buzatu, L.6
Cherniack, R.M.7
Rogers, R.M.8
Sciurba, F.C.9
Coxson, H.O.10
Pare, P.D.11
-
2
-
-
34548660457
-
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
-
DOI 10.1164/rccm.200703-456SO
-
Rabe KF, Hurd S, Anzueto A et al. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007; 176: 532-55. (Pubitemid 47403272)
-
(2007)
American Journal of Respiratory and Critical Care Medicine
, vol.176
, Issue.6
, pp. 532-555
-
-
Rabe, K.F.1
Hurd, S.2
Anzueto, A.3
Barnes, P.J.4
Buist, S.A.5
Calverley, P.6
Fukuchi, Y.7
Jenkins, C.8
Rodriguez-Roisin, R.9
Van, W.C.10
Zielinski, J.11
-
4
-
-
53749102775
-
A 4-year trial of tiotropium in chronic obstructive pulmonary disease
-
Tashkin DP, Celli B, Senn S et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N. Engl. J. Med. 2008; 359: 1543-54.
-
(2008)
N. Engl. J. Med.
, vol.359
, pp. 1543-1554
-
-
Tashkin, D.P.1
Celli, B.2
Senn, S.3
-
5
-
-
33645304010
-
Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease
-
Barnes NC, Qiu YS, Pavord ID et al. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 2006; 173: 736-43.
-
(2006)
Am. J. Respir. Crit. Care Med.
, vol.173
, pp. 736-743
-
-
Barnes, N.C.1
Qiu, Y.S.2
Pavord, I.D.3
-
6
-
-
0037108632
-
Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease
-
DOI 10.1164/rccm.2112055
-
Mahler DA, Wire P, Horstman D et al. Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2002; 166: 1084-91. (Pubitemid 35178706)
-
(2002)
American Journal of Respiratory and Critical Care Medicine
, vol.166
, Issue.8
, pp. 1084-1091
-
-
Mahler, D.A.1
Wire, P.2
Horstman, D.3
Chang, C.-N.4
Yates, J.5
Fischer, T.6
Shah, T.7
-
7
-
-
33847172367
-
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
-
DOI 10.1056/NEJMoa063070
-
Calverley PM, Anderson JA, Celli B et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. 2007; 356: 775-89. (Pubitemid 46294610)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.8
, pp. 775-789
-
-
Calverley, P.M.A.1
Anderson, J.A.2
Celli, B.3
Ferguson, G.T.4
Jenkins, C.5
Jones, P.W.6
Yates, J.C.7
Vestbo, J.8
-
8
-
-
0141558800
-
The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD
-
DOI 10.1378/chest.124.3.834
-
Hanania NA, Darken P, Horstman D et al. The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD. Chest 2003; 124: 834-43. (Pubitemid 37123298)
-
(2003)
Chest
, vol.124
, Issue.3
, pp. 834-843
-
-
Hanania, N.A.1
Darken, P.2
Horstman, D.3
Reisner, C.4
Lee, B.5
Davis, S.6
Shah, T.7
-
9
-
-
47249103757
-
Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations
-
Ferguson GT, Anzueto A, Fei R et al. Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations. Respir. Med. 2008; 102: 1099-108.
-
(2008)
Respir. Med.
, vol.102
, pp. 1099-1108
-
-
Ferguson, G.T.1
Anzueto, A.2
Fei, R.3
-
10
-
-
34247561439
-
Tiotropium in combination with placebo, salmeterol, or fluticasone- Salmeterol for treatment of chronic obstructive pulmonary disease: A randomized trial
-
Aaron SD, Vandemheen KL, Fergusson D et al. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann. Intern. Med. 2007; 146: 545-55. (Pubitemid 351650535)
-
(2007)
Annals of Internal Medicine
, vol.146
, Issue.8
, pp. 545-555
-
-
Aaron, S.D.1
Vandemheen, K.L.2
Fergusson, D.3
Maltais, F.4
Bourbeau, J.5
Goldstein, R.6
Balter, M.7
O'Donnell, D.8
McIvor, A.9
Sharma, S.10
Bishop, G.11
Anthony, J.12
Cowie, R.13
Field, S.14
Hirsch, A.15
Hernandez, P.16
Rivington, R.17
Road, J.18
Hoffstein, V.19
Hodder, R.20
Marciniuk, D.21
McCormack, D.22
Fox, G.23
Cox, G.24
Prins, H.B.25
Ford, G.26
Bleskie, D.27
Doucette, S.28
Mayers, I.29
Chapman, K.30
Zamel, N.31
FitzGerald, M.32
more..
-
11
-
-
34447498332
-
A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD
-
DOI 10.1016/j.pupt.2006.06.001, PII S1094553906000654
-
Cazzola M, Andò F, Santus P et al. A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-tovery severe COPD. Pulm. Pharmacol. Ther. 2007; 20: 556-61. (Pubitemid 47077647)
-
(2007)
Pulmonary Pharmacology and Therapeutics
, vol.20
, Issue.5
, pp. 556-561
-
-
Cazzola, M.1
Ando, F.2
Santus, P.3
Ruggeri, P.4
Di, M.F.5
Sanduzzi, A.6
D'Amato, M.7
-
12
-
-
0033825960
-
Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function
-
Nakano Y, Muro S, Sakai H et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am. J. Respir. Crit. Care Med. 2000; 162: 1102-8.
-
(2000)
Am. J. Respir. Crit. Care Med.
, vol.162
, pp. 1102-1108
-
-
Nakano, Y.1
Muro, S.2
Sakai, H.3
-
13
-
-
33745179158
-
Airflow limitation and airway dimensions in chronic obstructive pulmonary disease
-
DOI 10.1164/rccm.200601-037OC
-
Hasegawa M, Nasuhara Y, Onodera Y et al. Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2006; 173: 1309-15. (Pubitemid 43900704)
-
(2006)
American Journal of Respiratory and Critical Care Medicine
, vol.173
, Issue.12
, pp. 1309-1315
-
-
Hasegawa, M.1
Nasuhara, Y.2
Onodera, Y.3
Makita, H.4
Nagai, K.5
Fuke, S.6
Ito, Y.7
Betsuyaku, T.8
Nishimura, M.9
-
14
-
-
0027942484
-
Emphysema: Definition, imaging, and quantification
-
Thurlbeck WM, Müller NL. Emphysema: definition, imaging, and quantification. Am. J. Roentgenol. 1994; 163: 1017-25. (Pubitemid 24355686)
-
(1994)
American Journal of Roentgenology
, vol.163
, Issue.5
, pp. 1017-1025
-
-
Thurlbeck, W.M.1
Muller, N.L.2
-
15
-
-
0022569206
-
Centrilobular emphysema: CT-pathologic correlation
-
Foster WL Jr, Pratt PC, Roggli VL et al. Centrilobular emphysema: CT-pathologic correlation. Radiology 1986; 159: 27-32. (Pubitemid 16112185)
-
(1986)
Radiology
, vol.159
, Issue.1
, pp. 27-32
-
-
Foster Jr., W.L.1
Pratt, P.C.2
Roggli, V.L.3
-
16
-
-
0022559799
-
The diagnosis of emphysema. A computer tomographic-pathologic correlation
-
Bergin C, Müller N, Nichols DM et al. The diagnosis of emphysema. A computed tomographic-pathologic correlation. Am. Rev. Respir. Dis. 1986; 133: 541-6. (Pubitemid 16127234)
-
(1986)
American Review of Respiratory Disease
, vol.133
, Issue.4
, pp. 541-546
-
-
Bergin, C.1
Muller, N.2
Nichols, D.M.3
-
17
-
-
12144252928
-
The prediction of small airway dimensions using computed tomography
-
DOI 10.1164/rccm.200407-874OC
-
Nakano Y, Wong JC, de Jong PA et al. The prediction of small airway dimensions using computed tomography. Am. J. Respir. Crit. Care Med. 2005; 171: 142-6. (Pubitemid 40105413)
-
(2005)
American Journal of Respiratory and Critical Care Medicine
, vol.171
, Issue.2
, pp. 142-146
-
-
Nakano, Y.1
Wong, J.C.2
De, J.P.A.3
Buzatu, L.4
Nagao, T.5
Coxson, H.O.6
Elliott, W.M.7
Hogg, J.C.8
Pare, P.D.9
-
18
-
-
12344263724
-
Chronic obstructive pulmonary disease: Thin-section CT measurement of airway wall thickness and lung attenuation
-
DOI 10.1148/radiol.2342040013
-
Orlandi I, Moroni C, Camiciottoli G et al. Chronic obstructive pulmonary disease: thin-section CT measurement of airway wall thickness and lung attenuation. Radiology 2005; 234: 604-10. (Pubitemid 40139937)
-
(2005)
Radiology
, vol.234
, Issue.2
, pp. 604-610
-
-
Orlandi, I.1
Moroni, C.2
Camiciottoli, G.3
Bartolucci, M.4
Pistolesi, M.5
Villari, N.6
Mascalchi, M.7
-
19
-
-
0026871146
-
A self-complete measure for chronic airflow limitation: The St. George's Respiratory Questionnaire
-
Jones PW, Quirk FH, Baveystock CM et al. A self-complete measure for chronic airflow limitation: the St. George's Respiratory Questionnaire. Am. Rev. Respir. Dis. 1992; 145: 1321-7.
-
(1992)
Am. Rev. Respir. Dis.
, vol.145
, pp. 1321-1327
-
-
Jones, P.W.1
Quirk, F.H.2
Baveystock, C.M.3
-
20
-
-
0029849681
-
Human airway narrowing measured using high resolution computed tomography
-
Okazawa M, Müller N, McNamara AE et al. Human airway narrowing measured using high resolution computed tomography. Am. J. Respir. Crit. Care Med. 1996; 154: 1557-62. (Pubitemid 26391213)
-
(1996)
American Journal of Respiratory and Critical Care Medicine
, vol.154
, Issue.5
, pp. 1557-1562
-
-
Okazawa, M.1
Muller, N.2
Mcnamara, A.E.3
Child, S.4
Verburgt, L.5
Pare, P.D.6
-
21
-
-
36049046128
-
Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: A randomised controlled trial
-
DOI 10.1136/thx.2006.071068
-
Bourbeau J, Christodoulopoulos P, Maltais F et al. Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial. Thorax 2007; 62: 938-43. (Pubitemid 350084490)
-
(2007)
Thorax
, vol.62
, Issue.11
, pp. 938-943
-
-
Bourbeau, J.1
Christodoulopoulos, P.2
Maltais, F.3
Yamauchi, Y.4
Olivenstein, R.5
Hamid, Q.6
-
22
-
-
0030870119
-
Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid
-
Laitinen A, Altraja A, Kämpe M et al. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am. J. Respir. Crit. Care Med. 1997; 156: 951-8. (Pubitemid 27396441)
-
(1997)
American Journal of Respiratory and Critical Care Medicine
, vol.156
, Issue.3 I
, pp. 951-958
-
-
Laitinen, A.1
Altraja, A.2
Kampe, M.3
Linden, M.4
Virtanen, I.5
Laitinen, L.A.6
-
23
-
-
0030958324
-
Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: A placebo- Controlled study
-
Olivieri D, Chetta A, Del Donno M et al. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am. J. Respir. Crit. Care Med. 1997; 155: 1864-71. (Pubitemid 27256110)
-
(1997)
American Journal of Respiratory and Critical Care Medicine
, vol.155
, Issue.6
, pp. 1864-1871
-
-
Olivieri, D.1
Chetta, A.2
Del, D.M.3
Bertorelli, G.4
Casalini, A.5
Pesci, A.6
Testi, R.7
Foresi, A.8
-
24
-
-
0028240265
-
Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma
-
Trigg CJ, Manolitsas ND, Wang J et al. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am. J. Respir. Crit. Care Med. 1994; 150: 17-22. (Pubitemid 24209930)
-
(1994)
American Journal of Respiratory and Critical Care Medicine
, vol.150
, Issue.1
, pp. 17-22
-
-
Trigg, C.J.1
Manolitsas, N.D.2
Wang, J.3
Calderon, M.A.4
Mcaulay, A.5
Jordan, S.E.6
Herdman, M.J.7
Jhalli, N.8
Duddle, J.M.9
Hamilton, S.A.10
Devalia, J.L.11
Davies, R.J.12
-
25
-
-
0032845858
-
Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma
-
DOI 10.1016/S0091-6749(99)70379-9
-
Hoshino M, Takahashi M, Takai Y et al. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J. Allergy Clin. Immunol. 1999; 104: 356-63. (Pubitemid 29420433)
-
(1999)
Journal of Allergy and Clinical Immunology
, vol.104
, Issue.2 I
, pp. 356-363
-
-
Hoshino, M.1
Takahashi, M.2
Takai, Y.3
Sim, J.4
-
26
-
-
0032938331
-
Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment
-
Sont JK, Willems LN, Bel EH et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. Am. J. Respir. Crit. Care Med. 1999; 159: 1043-51. (Pubitemid 29202534)
-
(1999)
American Journal of Respiratory and Critical Care Medicine
, vol.159
, Issue.4 I
, pp. 1043-1051
-
-
Sont, J.K.1
Willems, L.N.A.2
Bel, E.H.3
Van, K.J.H.J.M.4
Vandenbroucke, J.P.5
Sterk, P.J.6
Apap, C.R.7
Roldaan, A.C.8
Van, K.K.W.9
Van, K.H.C.J.10
Evertse, C.E.11
Neeskens, P.12
Van, S.W.A.A.M.13
Hooijer, R.14
Cramer, G.15
Dijkstra, K.16
Dijkstra, N.17
Kluin-Nelemans, J.C.18
-
27
-
-
2442585161
-
Effect of short-term treatment with inhaled corticosteroid on airway wall thickening in asthma
-
DOI 10.1016/j.amjmed.2003.11.026, PII S0002934304000464
-
Niimi A, Matsumoto H, Amitani R et al. Effect of short-term treatment with inhaled corticosteroid on airway wall thickening in asthma. Am. J. Med. 2004; 116: 725-31. (Pubitemid 38622308)
-
(2004)
American Journal of Medicine
, vol.116
, Issue.11
, pp. 725-731
-
-
Niimi, A.1
Matsumoto, H.2
Amitani, R.3
Nakano, Y.4
Sakai, H.5
Takemura, M.6
Ueda, T.7
Chin, K.8
Itoh, H.9
Ingenito, E.P.10
Mishima, M.11
-
28
-
-
15844401603
-
Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD
-
DOI 10.1378/chest.127.3.965
-
Hashimoto M, Tanaka H, Abe S. Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD. Chest 2005; 127: 965-72. (Pubitemid 40775530)
-
(2005)
Chest
, vol.127
, Issue.3
, pp. 965-972
-
-
Hashimoto, M.1
Tanaka, H.2
Abe, S.3
-
29
-
-
0041853629
-
Bronchodilator reversibility testing in chronic obstructive pulmonary disease
-
DOI 10.1136/thorax.58.8.659
-
Calverley PM, Burge PS, Spencer S et al. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58: 659-64. (Pubitemid 36976273)
-
(2003)
Thorax
, vol.58
, Issue.8
, pp. 659-664
-
-
Calverley, P.M.A.1
Burge, P.S.2
Spencer, S.3
Anderson, J.A.4
Jones, P.W.5
-
30
-
-
42949152368
-
Bronchodilator responsiveness in patients with COPD
-
Tashkin DP, Celli B, Decramer M et al. Bronchodilator responsiveness in patients with COPD. Eur. Respir. J. 2008; 31: 42-50.
-
(2008)
Eur. Respir. J.
, vol.31
, pp. 42-50
-
-
Tashkin, D.P.1
Celli, B.2
Decramer, M.3
-
31
-
-
4344582266
-
Heterogeneity of narrowing in normal and asthmatic airways measured by HRCT
-
DOI 10.1183/09031936.04.00047503
-
King GG, Carroll JD, Müller NL et al. Heterogeneity of narrowing in normal and asthmatic airways measured by HRCT. Eur. Respir. J. 2004; 24: 211-18. (Pubitemid 39139787)
-
(2004)
European Respiratory Journal
, vol.24
, Issue.2
, pp. 211-218
-
-
King, G.G.1
Carroll, J.D.2
Muller, N.L.3
Whittall, K.P.4
Gao, M.5
Nakano, Y.6
Pare, P.D.7
-
32
-
-
38349076492
-
Heterogeneity of bronchoconstriction does not distinguish mild asthmatic subjects from healthy controls when supine
-
Kaminsky DA, Irvin CG, Lundblad LK et al. Heterogeneity of bronchoconstriction does not distinguish mild asthmatic subjects from healthy controls when supine. J. Appl. Physiol. 2008; 104: 10-19.
-
(2008)
J. Appl. Physiol.
, vol.104
, pp. 10-19
-
-
Kaminsky, D.A.1
Irvin, C.G.2
Lundblad, L.K.3
-
33
-
-
64849108483
-
Relationship between improved airflow limitation and changes in airway calibre induced by inhaled anticholinergic agents in COPD
-
Hasegawa M, Makita H, Nasuhara Y et al. Relationship between improved airflow limitation and changes in airway calibre induced by inhaled anticholinergic agents in COPD. Thorax 2009; 64: 332-8.
-
(2009)
Thorax
, vol.64
, pp. 332-338
-
-
Hasegawa, M.1
Makita, H.2
Nasuhara, Y.3
-
34
-
-
42149166529
-
Superiority of 'triple' therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD
-
DOI 10.1136/thx.2007.087213
-
Singh D, Brooks J, Hagan G et al. Superiority of 'triple' therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD. Thorax 2008; 63: 592-8. (Pubitemid 351969251)
-
(2008)
Thorax
, vol.63
, Issue.7
, pp. 592-598
-
-
Singh, D.1
Brooks, J.2
Hagan, G.3
Cahn, A.4
O'Connor, B.J.5
-
35
-
-
0028997564
-
Normal bronchial and pulmonary arterial diameters measured by thin section CT
-
Kim SJ, Im JG, Kim IO et al. Normal bronchial and pulmonary arterial diameters measured by thin section CT. J. Comput. Assist. Tomogr. 1995; 19: 365-9.
-
(1995)
J. Comput. Assist. Tomogr.
, vol.19
, pp. 365-369
-
-
Kim, S.J.1
Im, J.G.2
Kim, I.O.3
-
36
-
-
0034914236
-
Repeatability of quantitative CT indexes of emphysema in patients evaluated for lung volume reduction surgery
-
Gierada DS, Yusen RD, Pilgram TK et al. Repeatability of quantitative CT indexes of emphysema in patients evaluated for lung volume reduction surgery. Radiology 2001; 220: 448-54. (Pubitemid 32667183)
-
(2001)
Radiology
, vol.220
, Issue.2
, pp. 448-454
-
-
Gierada, D.S.1
Yusen, R.D.2
Pilgram, T.K.3
Crouch, L.4
Slone, R.M.5
Bae, K.T.6
Lefrak, S.S.7
Cooper, J.D.8
|